Chapter 360 Liver Transplantation
Indications
Broelsch CE, Edmond JC, Whitington TF, et al. Application of reduced-size liver transplant as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg. 1990;212:368-377.
Broelsch CE, Whitington PF, Emond JC, et al. Liver transplantation in children from living related donors: surgical techniques and results. Ann Surg. 1991;214:428.
Bucuvalas JD, Alonso E, Magee JC, et al. Improving long-term outcomes after liver transplantation in children. Am J Transplant. 2008;8:2506-2513.
Dell-Olio D, Kelly DA. Calcineurin inhibitor minimization in pediatric liver allograft recipients. Pediatr Transplant. 2009;13:670-681.
Jain A, Mazariegos G, Kashyap R, et al. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Transplantation. 2000;70(4):617-625.
Mazariegos GV, Reyes J, Marino IR, et al. Weaning of immunosuppression in liver transplant recipients. Transplantation. 1997;63:243-249.
Moreno Gonzalez E, Garcia Garcia I, et al. Liver transplantation in patients with thrombosis of the portal, splenic or superior mesenteric venin. Br J Surg. 1993;80:81.
Neuberger J, Gimson A. Selfless adults and split donor livers. Lancet. 2007;370:299-300.
Ng WL, Fecteau A, Shepherd R, et al. Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a North American multicenter registry. Pediatrics. 2008;122:e1128-e1135.
Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. 2008 OPTN/SRTR Annual Report: Transplant Data 1998–2007 (website). http://optn.org/AR2008. Accessed April 30, 2010
Reyes J, Gerber D, Mazariegos GV, et al. Split liver transplantation: a comparison of ex vivo and in situ techniques. J Pediatr Surg. 2000;35(2):283-290.
Reyes J, Jain A, Mazariegos G, et al. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. Transplantation. 2000;69:2573-2580.
Rogiers X, Malago M, Gawag K, et al. In situ splitting of cadaveric livers: the ultimate expansion of a limited donor pool. Ann Surg. 1996;224:331-341.
Schwartz R, Dameshek W. Drug-induced immunological tolerance. Nature. 1959;183:1682-1683.
Sokal EM, Caragiozoglou T, et al. Epstein-Barr virus serology and Epstein-Barr virus–associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation. 1993;56:1294.
Starzl TE, Demetris AJ. Liver transplantation: a 31-year perspective. Part III. Curr Probl Surg. 1990;27:181-240.
Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology. 1993;17:1127-1152.
Starzl TE, Marchioro TL, Waddell WR, et al. The reversal of rejection in human renal homografts with subsequent development of tolerance. Surg Gynecol Obstet. 1963;117:385-395.
Starzl TE, Hakala TR, Shaw BWJr, et al. A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet. 1984;158:223-230.
Stratta RJ, Schaeffer MS, Markin RS, et al. Cytomegalovirus infection and disease after liver transplantation: an overview. Dig Dis Sci. 1992;37:673.
Todo S, Nery J, Yanaga K, et al. Extended preservation of human liver grafts with UW solution. JAMA. 1989;261:711-714.
United Network for Organ Sharing (UNOS)/Organ Procurement and Transplantation Network (OPTN). Home page (website). www.unos.org. Accessed April 30, 2010